Spondyloarthritis & psoriatic arthritis

Calprotectin (S100A8/A9) is not associated with ultrasound-detected synovitis in a longitudinal study of patients with psoriatic arthritis treated with biological disease-modifying anti-rheumatic drugs

Scand J RheumatolPublished Prospective longitudinal cohort study

Authors' conclusion

Calprotectin levels were elevated in PsA patients and decreased with treatment but showed no clinically significant correlation with ultrasound-detected synovitis.

Study context

Population
Psoriatic arthritis (PsA) patients initiating biological disease-modifying anti-rheumatic drug (bDMARD) therapy, assessed clinically and by US at baseline and after 3, 6, 9 and 12 months
Participants
43 patients
Exposure
Plasma calprotectin vs ultrasound-detected synovitis in PsA patients initiating bDMARD therapy
  • PsAn = 43
Outcome
Association of plasma calprotectin with US-detected synovitis before and during bDMARD treatment
Methodological detailsMean (± SD) age 47.6 (± 12.9) years; 60.5% women; median disease duration 10 years (IQR 4.2-21.9)
  • Mean (± SD) age 47.6 (± 12.9) years; 60.5% women; median disease duration 10 years (IQR 4.2-21.9)

Main finding

As reported in the abstract

Correlation between US scores and inflammatory markers
  • No clinically relevant correlations between the US scores and inflammatory markers

Observational data: associations, not effects.

Further findings

OutcomeP value
Baseline calprotectin, S100A12, IL-6, IL-17A, IL-23 and CXCL10 levelsHigher in PsA than in controlsP < 0.05

Change in calprotectin, S100A12 and IL-6 levels during follow-up

Calprotectin, S100A12 and IL-6 levels decreased during follow-up (p < 0.05)

Joint counts, DAPSA, DAS28-CRP and BASDAI

Significant reductions

Original publication

Calprotectin (S100A8/A9) is not associated with ultrasound-detected synovitis in a longitudinal study of patients with psoriatic arthritis treated with biological disease-modifying anti-rheumatic drugs. Scand J Rheumatol. Published 13 August 2025. doi:10.1080/03009742.2025.2523667

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.